BSEVivanza Biosciences LtdMediumNegative
Announced Tue, 17 Mar · 14:42 IST

Pursuant to Regulation 30 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 We wish to inform you that Mr. Hemant Amrish Parikh (DIN: 00027820) has tendered his ....

Management Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.5%1-day move
₹1.90
prior close
₹1.90
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.0+0.0+0.5+0.5+0.5-4.2-4.2-5.3+10.0+10.5-3.7-2.1
Up moveDown movePending
AI summary

Mr. Hemant Amrish Parikh (DIN: 00027820) has resigned as a Non-Executive Director of Vivanza Biosciences Ltd with effect from the close of business hours on March 17, 2026. The reason cited is personal reasons, and the director has confirmed there are no material reasons for his resignation beyond what is mentioned in his resignation letter. The company, led by Managing Director Jayendra Mehta (DIN: 08210602), has disclosed this to BSE under SEBI Listing Regulations. The resignation letter and required Annexure-A details have been filed with the stock exchange.

Likely market impact

This is a routine single non-executive director resignation for personal reasons with no material concerns flagged, and is unlikely to have any meaningful impact on the company's operations or stock price.